Recently, foreign medical companies have released intensive financial reports, and investors are highly concerned about the impact of weight loss drug GLP-1 on medical device and equipment manufacturers. Most manufacturers believe that such drugs have little short-term impact on their business, but invasive weight loss surgical equipment manufacturers have already been significantly impacted.